I believe Omontys will be back with further warnings and closer monitoring when administering and after administration. This drug is too valuable to be taken off and ceasing to exist.
Remember, these are very sick people to begin with and note that there are many drugs out there that can cause death.
Sum it up: O will be back with additional warning/monitoring. AFFY did the right thing by pulling the drug off the shelf for the time being.
I understand how you can be very bearish considering patients died, but patients die in hospitals all the time and from over the counter drugs, and administered drugs, etc. I believe with closer monitoring like Amgens drug that O will be back soon. I will also boldly say that not only will it be back but be a blockbuster overtime and one investing now and NOT shorting can reap the rewards. I will state again, not 1 single share for sale under $15.